SAN DIEGO, April 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc.
(Nasdaq: AMLN) today reported financial results for the quarter ended March
31, 2008....
SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at its Research & Development (R&D) Day on Wednesday, November 28, 2007...
- Both Groups Experienced Significant Weight Loss -
- New Drug Application Filing Planned by the End of the First Half of 2009 -
SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., Oct. 31...
#4: Amylin Pharmaceuticals to Webcast Third Quarter Results and Gilead Submits Marketing Applications in the United States and European Union for Viread(R) (Tenofovir Disoproxil Fumarate) for the Treatment of Chronic Hepatitis B
Biotechnology industry alert provided by U.S. Equity News. Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) will webcast its Quarterly Update Conference Call for the third quarter of 2007 on...
SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly Update Conference Call for the third quarter of 2007 on Wednesday,...
Biotechnology industry alert provided by U.S. Equity News. Medarex, Inc. (Nasdaq: MEDX) recently announced that it is scheduled to present at the Natixis Bleichroeder's Hidden Gems...
SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 22, 2005--Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today...